CSIMarket
 


Natera inc   (NTRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Natera Inc 's Total Debt to Equity for Trailing Twelve Months Period

NTRA's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

NTRA Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 8.44 % 116.98 % 34.09 % 19.96 % 8.03 %
Y / Y Total Debt Growth 0.37 % 9.52 % 9.55 % 9.56 % 9.55 %
Total Debt to Equity for Trailing Twelve Months Period 0.52 0.53 0.61 0.64 0.66
Total Ranking # 1046 # 1596 # 1824 # 1952 # 2272
Seq. Equity Growth -2.46 % 31.62 % -8.37 % -7.82 % 95.16 %
Seq. Total Debt Growth 0.08 % 0.09 % 0.09 % 0.1 % 9.21 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite net new borrowings of 0.08% Natera Inc managed to decrease Total Debt to Equity for Trailing Twelve Months Period in IV. Quarter to 0.52, below Natera Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Laboratories industry 5 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Natera Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
NTRA Charts and Quotes
Total Debt to Equity NTRA in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 6
Sector # 127
S&P 500 # 991


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
24.31 2.38 0.41
(Sep 30 2018)   (Mar 31 2017)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Laboratories Industry Total Debt to Equity for Trailing Twelve Months Period
Ge Healthcare Technologies Inc   1.43 
Inotiv Inc   1.40 
Malachite Innovations Inc   1.38 
Fortrea Holdings Inc   0.93 
Charles River Laboratories International inc   0.82 
Exagen Inc   0.76 
Exact Sciences Corporation  0.75 
Syneos Health Inc   0.75 
Quest Diagnostics Inc  0.68 
Koninklijke Philips Nv  0.57 
Hologic Inc  0.55 
Laboratory Corporation Of America Holdings  0.51 
Natera inc   0.50 
American Shared Hospital Services  0.49 
Icon Plc  0.44 
National Research Corporation  0.39 
Luna Innovations Inc  0.30 
Aclarion Inc   0.29 
Celcuity Inc   0.27 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com